Abstract
Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease associated with major obstetrical complications such as gestational loss, preterm delivery, fetal growth restriction (FGR) and preeclampsia. Published literature is not consensual regarding the main risk factors for each of these outcomes. Our goal with this study was to determine the most important predictors for each of the main adverse pregnancy outcomes in this population. We conducted a retrospective cohort study of unifetal pregnancies of women with the diagnosis of SLE followed in our unit between January 1994 and December 2016. We excluded elective terminations of pregnancy and cases lost to follow-up and we analyzed 157 pregnancies (128 women). Multiple logistic regression models for the outcomes gestational loss, preterm delivery, fetal growth restriction, and preeclampsia were built. Two-sided p-values of < 0.05 were used to determine statistical significance, and two-sided confidence intervals of 95% are reported. In our cohort, the main risk factors for gestational loss were maternal age and the presence of antiphospholipid antibodies. Lupic nephritis was predictive of a preterm delivery and preeclampsia. Renal involvement and lupus flares during pregnancy were risk factors for FGR. Overall, the main risk factor for an adverse pregnancy outcome were lupus flares during pregnancy. Despite optimal pregnancy monitoring, women with SLE are still at risk for adverse pregnancy outcomes. Risk stratification for each of these outcomes is crucial for an effective counselling and tailored monitoring.
Similar content being viewed by others
References
Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 56(11):1945–1961
Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262
Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS (1998) Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 41(10):1714–1724
Lateef A, Petri M (1994) Systemic lupus erythematosus and pregnancy. Rheum Dis Clin N Am 20(1):87–118
Clowse MEB, Jamison M, Myers E, James AH (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199(2):127.e1–127.e6
Peart E, Clowse MEB (2014) Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 26(2):118–123
Liu J, Zhao Y, Song Y, Zhang W, Bian X, Yang J, Liu D, Zeng X, Zhang F (2012) Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med 25(3):261–266
Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA (2014) Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res 60(2–3):184–192
Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC (2004) Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European forum on antiphospholipid antibodies. Thromb Res 114(5–6):553–558
Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulant. Thromb Haemost 74(04):1185–1190
Gayed M, Gordon C (2007 Nov 1) Pregnancy and rheumatic diseases. Rheumatology (Oxford) 46(11):1634–1640
Ko HS, Ahn HY, Jang DG, Choi S-K, Park Y-G, Park IY, Lee G, Park SH, Shin JC (2011) Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci 8(7):577–583
Uramoto KM, Michet CJ, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42(1):46–50
Smyth A, Oliveira GHM, Lahr BD, Bailey KR, Norby SM, Garovic VD (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5(11):2060–2068
Ostensen M, Clowse M (2013) Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol 25(5):591–596
Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA (2016) Differences in disease phenotype and severity in SLE across age groups. Lupus. 25(14):1542–1550
Clowse MEB, Magder LS, Witter F, Petri M (2005 Feb) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52(2):514–521
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that there are no conflicts of interest.
Ethical Approval
This was a retrospective, observational study that in our institution did not require specific ethics approval.
Informed Consent
This was a retrospective, observational study that in our institution, did not require specific informed consent.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 283 kb)
Rights and permissions
About this article
Cite this article
Palma dos Reis, C.R., Cardoso, G., Carvalho, C. et al. Prediction of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus. Clinic Rev Allerg Immunol 59, 287–294 (2020). https://doi.org/10.1007/s12016-019-08762-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-019-08762-9